Kadima Neuropsychiatry Institute — La Jolla, California

Public research footprint of Kadima Neuropsychiatry Institute, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Major Depressive Disorder · Treatment Resistant Depression · Generalized Anxiety Disorder · Depressive Disorder, Treatment-Resistant

Recently updated registry entries

NCT06941844 — A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge) (Active Not Recruiting)
NCT06308653 — Psilocybin for Major Depressive Disorder (MDD) (Active Not Recruiting)
NCT07284667 — ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Kadima Neuropsychiatry Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.